The Biotech Growth Trust PLC (LON:BIOG - Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 958.04 ($12.09) and traded as low as GBX 850.45 ($10.73). The Biotech Growth Trust shares last traded at GBX 852 ($10.75), with a volume of 48,347 shares trading hands.
The Biotech Growth Trust Trading Down 1.1 %
The company has a market cap of £239.41 million, a PE ratio of 2.81 and a beta of 0.50. The company has a current ratio of 0.59, a quick ratio of 0.00 and a debt-to-equity ratio of 11.02. The stock has a 50 day moving average price of GBX 867.04 and a 200 day moving average price of GBX 955.78.
The Biotech Growth Trust (LON:BIOG - Get Free Report) last released its earnings results on Wednesday, November 27th. The company reported GBX 0.20 ($0.00) EPS for the quarter. The Biotech Growth Trust had a return on equity of 26.96% and a net margin of 95.33%.
Insider Buying and Selling at The Biotech Growth Trust
In related news, insider Julie Tankard acquired 1,022 shares of the stock in a transaction on Wednesday, December 4th. The stock was acquired at an average price of GBX 972 ($12.26) per share, for a total transaction of £9,933.84 ($12,533.23). Also, insider Nicola Shepherd acquired 1,000 shares of the stock in a transaction on Monday, January 13th. The shares were bought at an average price of GBX 846 ($10.67) per share, with a total value of £8,460 ($10,673.73). Over the last 90 days, insiders purchased 6,222 shares of company stock worth $5,659,584. 0.71% of the stock is owned by insiders.
About The Biotech Growth Trust
(
Get Free Report)
The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).
Featured Articles
Before you consider The Biotech Growth Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Biotech Growth Trust wasn't on the list.
While The Biotech Growth Trust currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
